Judith Aberg, MD
Enriched profileProfessor Emeritus, Medicine, Infectious Diseases · Icahn School of Medicine at Mount Sinai
Judith Aberg is Professor Emeritus, Medicine, Infectious Diseases at Icahn School of Medicine at Mount Sinai. OpenAlex indexes 376 publications with 23,354 citations (h-index 73); ClinicalTrials.gov lists 11 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 5% of Infectious Disease profiles in the FindMyKOL directory.
Data verified 23 Oct 2026
Overview
Updated 28 Oct 2026
Judith A. Aberg, M.D., is Professor Emeritus, Medicine, Infectious Diseases at Icahn School of Medicine at Mount Sinai. The public record shows 376 publications with 23,354 citations (h-index 73), centered on HIV-related health complications and treatments, HIV/AIDS Research and Interventions, HIV/AIDS drug development and treatment. It also documents an investigator role on 11 registered clinical trials, industry payments reported by 7 companies, 5 NIH-funded awards (2004–2014).
- Most recent indexed publication: 2026 · Open forum infectious diseases
- Top research focus: HIV-related health complications and treatments
- 11 registered trials on ClinicalTrials.gov
- Open Payments reporting from 7 companies
Generated from the cited public record · current as of 28 Oct 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 28 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 195.
Clinical & industry
trials, payments and federal fundingPublic positions
sourced statements on record- verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.mountsinai.org ↗
- verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.mountsinai.org ↗
Contact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 28 Oct 2026
Listed as an investigator on 11 registered studies on ClinicalTrials.gov. The most recent:
- Modulation of Immune Activation by Aspirin
Sponsor: Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections
- Pharmacokinetic Study of Pitavastatin and Ritonavir-Boosted Darunavir or Efavirenz
Sponsor: NYU Langone Health
- Atorvastatin on Biomarkers of Inflammation, Coagulopathy, Angiogenesis & T-cells
Sponsor: Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections
Industry payments
Updated 28 Oct 2026
7 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- Merck Sharp & Dohme LLCProgram year20254 payments
- Theratechnologies Inc.Program year20251 payment
- Invivyd IncProgram year20241 payment
Medicare prescribing footprint (2019)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Nervous system
100%gamma-Aminobutyric Acid A Receptor Positive Modulator100%Zolpidem Tartrate100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
Updated 28 Oct 2026
5 NIH research awards on record, funded 2004–2014 per NIH RePORTER. The latest:
- New York University HIV/AIDS Clinical Trial Unit
New York University School of Medicine
FY2014$67,226UM1AI069532 - New York University HIV/AIDS Clinical Trial Unit
New York University School of Medicine
FY2013$1,344,582UM1AI069532 - New York University HIV/AIDS Clinical Trial Unit
New York University School of Medicine
FY2012$1,460,503UM1AI069532
Publications
Updated 28 Oct 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Hypertension Prevalence and Control at Trial Entry in the REPRIEVE Study Population: Results From a Secondary Analysis.
Open forum infectious diseases
Clinical Trial2026 - Safety and Immunogenicity of BNT162b2 in Antiretroviral Therapy-Treated People With HIV.
Open forum infectious diseases
Clinical Trial2026 - A tool based on objective data to identify patients at elevated risk of hospital-onset Staphylococcus aureus bacteremia: a nested case-control study.
Antimicrobial stewardship & healthcare epidemiology
Article2026 - Heart Failure Risk and Events in People With HIV: The Randomized Trial to Prevent Vascular Events in HIV (REPRIEVE).
Circulation. Heart failure
Clinical Trial2026 - Effect of Pitavastatin on Epigenetic Aging Biomarkers in People With HIV: Pilot Substudy of the REPRIEVE Trial.
Clinical infectious diseases
Clinical Trial2026
Most-cited works
by citation count (OpenAlex)- 01An inflammatory cytokine signature predicts COVID-19 severity and survivalArticle2,598 citations2020
- 02Robust neutralizing antibodies to SARS-CoV-2 infection persist for monthsArticle1,193 citations2020
- 03Development of a Definition of Postacute Sequelae of SARS-CoV-2 InfectionArticle848 citations2023
- 04
- 05AKI in Hospitalized Patients with COVID-19Article803 citations2020
Network
Updated 28 Oct 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 28 Oct 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Doximity
doximity.com/pub/judith-aberg-md
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →doximity.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 28 Oct 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- MD
Pennsylvania State University (medical degree)
verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.mountsinai.org ↗ - verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →idsociety.org ↗
Editorial & leadership roles
journal and society appointments- verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →idsociety.org ↗
- verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →idsociety.org ↗
- Editorial board member
three infectious disease journals (journals not named)
verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.mountsinai.org ↗ - Fellow
Infectious Diseases Society of America (FIDSA)
verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →idsociety.org ↗ - Fellow
American College of Physicians (FACP)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →infectiousdiseases.wustl.edu ↗
Awards & honors
honors on the public record- verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →idsociety.org ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →infectiousdiseases.wustl.edu ↗
Secondary affiliations
appointments beyond the home institution- Infection Prevention and Infectious Diseases Expert
Mount Sinai Health System Emergency Operations Center
verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.mountsinai.org ↗
Media & interviews
press, podcasts and appearances- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →iasusa.org ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Deepak Bhatt, MD
Icahn School of Medicine at Mount Sinai
Gregg Stone, MD
Icahn School of Medicine at Mount Sinai
Jonathan Halperin, MD
Icahn School of Medicine at Mount Sinai
Donna Mancini, MD
Icahn School of Medicine at Mount Sinai
Thomas Walsh, MD
Cornell University
Douglas Richman, MD
University of California San Diego
Vance Fowler, MD
Duke University
Myron Cohen, MD
University of North Carolina at Chapel Hill School of Medicine